Australia markets closed

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
24.94+0.50 (+2.05%)
At close: 04:00PM EDT
24.94 0.00 (0.00%)
After hours: 04:03PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts6677
Avg. Estimate-0.47-0.49-1.94-2.2
Low estimate-0.55-0.59-2.24-2.63
High estimate-0.36-0.37-1.57-1.86
Year ago EPS-0.42-0.43-1.65-1.94
Revenue estimateCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
No. of analysts5577
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202129/09/202130/12/202130/03/2022
Est. EPS-0.39-0.4-0.41-0.42
Actual EPS-0.42-0.43-0.4-0.46
Difference-0.03-0.030.01-0.04
Surprise %-7.70%-7.50%2.40%-9.50%
EPS trendCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Current estimate-0.47-0.49-1.94-2.2
7 days ago-0.47-0.48-1.88-2.1
30 days ago-0.44-0.47-1.8-2.08
60 days ago-0.45-0.48-1.87-2.19
90 days ago-0.41-0.42-1.78-2.08
EPS revisionsCurrent qtr. (Jun 2022)Next qtr. (Sep 2022)Current year (2022)Next year (2023)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A11
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1123
Growth estimatesCEREIndustrySector(s)S&P 500
Current qtr.-11.90%N/AN/AN/A
Next qtr.-14.00%N/AN/AN/A
Current year-17.60%N/AN/AN/A
Next year-13.40%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A